To: Qone0 who wrote (33747 ) 8/18/2021 3:31:56 PM From: Sun Tzu 3 RecommendationsRecommended By ajtj99 tntpal towerdog
Read Replies (1) | Respond to of 97945 Little fun stories to share...in the late '80s I worked at a major R&D lab. We had a policy to search every bag and briefcase on its way out (ya, they were very nice internally and provided a lot of perks, but no compromises on the security and secrecy - more on this later). One day a VP of some company came to visit us and take a tour. To his shock, he was asked to open his briefcase on his way out. When he objected, the security pointed to his consent on the sign-in sheet. So eventually he relented b/c they assured him the briefcase was not going to leave the building until it was searched. Long story short, security found one of our prototype boards in his briefcase. Prior to that, I worked in an IBM lab. To get to my office, first you had to have a special badge to let you into that specific building (company badge was not enough). Then you needed a separate badge just for the hallway that led to my side of the floor. And finally you had to punch in a code into the room that was a raised floor. My desk was there. It was just me and one other colleague working in that room (plus the sensitive equipment, of course). Anyways, one day we got bored and decided to redecorate the room by moving our desks around and change the setup. Suddenly alarms sounded, red lights flashed, and the door got bolted. Security contacted us over the speakers to ask what is going on. We told him that we moved the desks but all is ok. He said, that is fine. But next time please schedule it so we know what to expect. Turns out the floor had pressure sensors in case someone tried to steal one of the minicomputers or other equipment. R&D is always an attack target and companies are always very protective of it. So QS being secretive doesn't surprise me. Of course this also provides a cover for fraud. But being secretive is not an indication of hiding something illegitimate. And you are right that they are not expected to have something to sell until 2025 and many things can happen till then. Which is why I say they should be treated like a phase 2 biotech.